Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials.

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco-25-01003
Affiliations:
14
Authors:
22
Go to article
Institutions Authors Share
National Cancer Center Hospital East, Japan
4.000000
 0.18
University of Pisa (UNIPI), Italy
3.000000
 0.14
IRCCS Istituto Oncologico Veneto (IOV), Italy
2.000000
 0.09
University Hospital of Pisa, UNIPI, Italy
2.000000
 0.09
USC Norris Comprehensive Cancer Center, United States of America (USA)
2.000000
 0.09
Charité - University Medicine Berlin, Germany
2.000000
 0.09
IRCCS National Cancer Institute (INT) Milan, Italy
2.000000
 0.09
Aichi Cancer Center Hospital, Japan
1.000000
 0.05
Takeda, Japan
1.000000
 0.05
UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), United States of America (USA)
1.000000
 0.05
Kyushu University, Japan
1.000000
 0.05
Agostino Gemelli University Polyclinic, Italy
0.500000
 0.02
Catholic University of the Sacred Heart (UCSC), Italy
0.500000
 0.02
Interested in Oncology and Carcinogenesis?